Pulse oximetric saturation to fraction of inspired oxygen (SpO2/FIO2) ratio 24 hours after high-flow nasal cannula (HFNC) initiation is a good predictor of HFNC therapy in patients with acute exacerbation of interstitial lung disease.
Takafumi KoyauchiHideki YasuiNoriyuki EnomotoHirotsugu HasegawaHironao HozumiYuzo SuzukiMasato KarayamaKazuki FuruhashiTomoyuki FujisawaYutaro NakamuraNaoki InuiKoshi YokomuraTakafumi SudaPublished in: Therapeutic advances in respiratory disease (2021)
HFNC was well tolerated in patients with AE-ILD, suggesting that HFNC is a reasonable respiratory management for these patients. The SpO2/FIO2 ratio 24 h after initiating HFNC was a good predictor of successful HFNC treatment. The reviews of this paper are available via the supplemental material section.
Keyphrases
- interstitial lung disease
- systemic sclerosis
- end stage renal disease
- rheumatoid arthritis
- ejection fraction
- idiopathic pulmonary fibrosis
- chronic obstructive pulmonary disease
- chronic kidney disease
- newly diagnosed
- blood pressure
- peritoneal dialysis
- extracorporeal membrane oxygenation
- randomized controlled trial
- intensive care unit
- obstructive sleep apnea
- bone marrow
- mesenchymal stem cells
- cell therapy
- patient reported